Table 3:
Phenotype | CHR | BP | variant | Gene | Minor Allele |
Major Allele |
AA MAF |
EA MAF |
EA P value |
COGA AA+EA P value |
Yale- Penn-AA P value |
SAGE- AA P value |
SAGE EA P value |
OZALC EA P value |
Meta P value |
Direction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DSM -IV AD | 1 | 174,637,937 | rs61826952 | RABGAP1L | G | A | 0.10 | 0.07 | 7.73E-06 | 8.42E-11 | 0.01 | 0.13 | 0.46 | 0.24 | 1.66E-04 | −−++−− |
Time spent drinking | 2 | 123,424,651 | rs7597960 | TSN,LINC01826 | T | A | 0.65 | 0.21 | 4.43E-06 | 1.22E-08 | 0.23 | 8.94E-03 | 0.83 | 0.33 | 8.86E-05 | −−−+−+ |
DSM -IV AD | 4 | 100,239,319 | rs1229984 | ADH1B | T | C | 0.01 | 0.03 | 2.09E-07 | 1.72E-08 | 0.82 | 0.11 | 0.54 | 0.01 | 5.30E-09 | −−+−−− |
DSM -IV AD criterion count | 4 | 100,239,319 | rs1229984 | ADH1B | T | C | 0.01 | 0.03 | 4.16E-11 | 2.61E-13 | 0.86 | 0.01 | 0.10 | 0.06 | 4.09E-10 | −−+−−− |
Desire to cut drinking | 4 | 100,239,319 | rs1229984 | ADH1B | T | C | 0.01 | 0.03 | 1.21E-11 | 6.01E-14 | 0.82 | 0.03 | 4.89 E-03 |
5.52E-03 | 9.79E-18 | −−+−−− |
Tolerance | 4 | 100,239,319 | rs1229984 | ADH1B | T | C | 0.01 | 0.03 | 1.89E-07 | 8.06E-09 | 0.95 | 7.31E-03 | 0.32 | 0.14 | 1.20E-09 | −−−−−− |
Drinking more than intended | 8 | 127,213,398 | rs188227250 | LINC00861, LOC101927657 | A | G | 0.02 | 0.03 | 6.72E-09 | 1.03E-06 | - | - | 0.91 | 1.96E-03 | 3.71E-09 | +−+ |
Time spent drinking | 15 | 36,344,539 | rs1912461 | MIR4510,C15orf41 | C | T | 0.02 | 0.01 | 1.77E-08 | 1.60E-05 | - | - | 0.18 | 0.12 | 2.31E-08 | +++ |
Minor allele is defined as minor allele in EA samples. Directions of effect are in terms of minor alleles with + and – meaning increasing or decreasing the chance of having AD or DSM-IV AD criterion, or the number of DSM-IV AD criterion count. For significant findings in COGA AA+EA, the order of directions are: COGA AA, EA, Yale-Penn-AA, SAGE-AA, SAGE-EA, OZALC-EA; for significant findings in EA, the order of directions are: EA, SAGE-EA, OZALC-EA.